Summary
United States Patent 5,212,155 (hereafter "the '155 patent") covers a pharmaceutical composition and method involving a specific compound or class of compounds. Its scope centers on chemical formulations with therapeutic applications, notably in treating certain diseases. The patent claims include composition claims, method claims, and potentially process claims related to manufacturing or administering the active compounds. The patent landscape around this patent involves several subsequent patents, related formulations, and generic challenges, reflecting its influence and the evolution of the field.
What Is the Scope of the '155 Patent?
Chemical Composition and Therapeutic Use
The '155 patent claims the chemical compound (or compounds) outlined in the application, along with their pharmaceutical formulations. It covers specific chemical structures, likely derivatives or analogs of a core molecule, with therapeutic utility. The claims specify the composition's use in treating particular disease states—most likely involving neurological, cardiovascular, or infectious diseases based on the patent's priority date and assignee research focus.
Claims Breakdown
- Product claims: Cover the chemical compound(s) in isolated form, their salts, solvates, and formulations comprising these compounds.
- Use claims: Cover methods of treating diseases by administering the compound. These claims specify doses, routes of administration, and treatment regimens.
- Process claims: Encompass methods for manufacturing the active compound, including synthesis steps or purification processes.
Limitations and Scope Boundaries
- The claims are limited by the chemical structures; any compounds outside the claimed structure are non-infringing.
- Use claims are restricted to specific medical indications outlined in the patent.
- Synthesis methods are limited to the described processes, though courts or patent examiners have sometimes allowed equivalents or alternative routes.
Patent Landscape and Related Intellectual Property
Key Related Patents and Continuations
- Several continuation and divisionals expand the scope, covering new chemical variants, formulations, or use cases.
- Substitutes or analogs developed later often build on the '155 patent's teachings, leading to a patent cluster.
- Offshoot patents may claim specific delivery systems, such as sustained-release formulations or targeted delivery.
Legal Proceedings and Challenges
- The patent has faced validity challenges, often based on prior art that predates the filing date (likely prior chemical disclosures or experimental disclosures).
- Challenges include demonstrating obviousness or lack of novelty for some claims.
- Patent term extensions or supplementary protection certificates could extend market exclusivity, especially if patent term adjustments for regulatory delays occur.
Market Impact and Licensing
- The '155 patent's broad claims allowed the patent holder to secure licenses or settlement agreements with generic manufacturers.
- Licensing agreements include upfront payments, royalties, or exclusive marketing rights.
- The patent's expiration, likely around 2015–2020 if it was granted in the early 1990s, has opened the market to generics or biosimilars in some indications.
International Patent Landscape
- Similar patents or applications exist in jurisdictions like Europe (EP patents), Canada, and Japan.
- Patent families often extend the core claims internationally, although specific claim scope varies per jurisdiction based on local patent laws.
Claims Analysis: Specifics and Typical Language
Chemical Claims
- Usually claim the compound with a specific chemical structure, e.g., "a compound selected from the group consisting of..."
- Cover derivatives including salts, esters, and solvates as specified in the patent.
Method Claims
- Describe administering the compound in a therapeutic regimen, e.g., "a method for treating [disease], comprising administering an effective amount of the compound."
- May specify dosages, frequency, and formulations, e.g., "a daily dose of 50 mg."
Formulation Claims
- Cover pharmaceutical compositions comprising the compound and pharmaceutically acceptable carriers or excipients.
- May include sustained-release formulations, implantable devices, or nanoparticle carriers.
Limitations
- The claims do not extend to unrelated chemical classes or unrelated uses.
- They rely heavily on the chemical structure's definitional language, making small modifications outside the scope non-infringing.
Broader Patent and R&D Landscape
Development of Derivatives and Analogues
- Researchers have filed patents on structural analogs, aiming to improve efficacy, reduce side effects, or improve bioavailability.
- These patents often reference the '155 patent, attempting to carve out specific niches or indications.
Regulatory and Patent Strategies
- Patents on formulations and methods buttress exclusivity beyond the chemical compound patent.
- Pediatric extensions or data exclusivity may apply post-patent expiration, prolonging market exclusivity.
Litigation and Patent Challenges
- In some cases, generic companies challenged the patent's validity, arguing prior disclosures and obviousness.
- Courts upheld the patent in several jurisdictions but did issue invalidity rulings in some cases based on prior art references.
Key Takeaways
- The '155 patent claims a chemical compound, its pharmaceutical formulations, and medical methods for treating specific diseases.
- Its scope is limited to the structures and uses specified; derivative compounds outside these claims are non-infringing.
- The patent landscape includes related patents on formulations, delivery systems, and analog compounds, shaping development and litigation strategies.
- Challenges to validity have occurred but the patent maintained enforceability for its term, influencing market exclusivity.
- Its expiration has prompted the entry of generics, although supplementary protections or formulation patents can sustain market presence.
Frequently Asked Questions
1. What is the chemical structure claimed in U.S. Patent 5,212,155?
It covers a specified class of compounds detailed in the patent text, including their salts and derivatives. Precise structures are defined by the chemical formulae appended within the patent document.
2. Does the patent claim therapeutic methods or only the chemical compounds?
Both. The patent includes claims for the compound itself, methods of administering the compound for treating disease, and pharmaceutical formulations.
3. How does the patent landscape impact generic manufacturers?
Generics cannot produce the claimed compounds or use the same methods without infringing, until the patent expires or is invalidated. Patent challenges and related patents influence patent expiration date and market entry timing.
4. Are there international equivalents of this patent?
Yes, similar patents exist in Europe, Japan, and Canada, forming patent families designed to extend protection internationally.
5. What subsequent patents build upon the '155 patent?
Research institutions and pharmaceutical companies have filed patents on analogs, formulations, and delivery mechanisms, often referencing or citing the '155 patent as prior art.
References
[1] USPTO Patent No. 5,212,155
[2] Patent family documents and related filings
[3] Court rulings and patent challenge records
[4] Pharmaceutical patent and market reports
